CD44 and breast carcinoma: In this review, we focus upon the biology of CD44 and RHAMM because—unlike LYVE1, STAB2/HARE, and LAYN—these receptors have been studied in detail in the context of cutaneous wound repair and breast cancer [8] and because they are well characterized to directly bind to HA [60].